semaglutide face changes Surprising Ozempic & Skin From GLP-1 Drugs TrimRX | Ozempic Face: What

Clinical considerations for discontinuation include but are not limited to pregnancy, adjudicationconfirmed pancreatitis, malignancy, a BMI of 18.5 kg/m 2 , treatment with bariatric surgery, or a systemic hypersensitivity reaction

Most Common Early Side Effects and Their Duration Nausea and vomiting rank as the top reported side effects in the first two weeks, affecting 2540% of semaglutide users at therapeutic doses

Quick Answer: Current evidence does not establish that GLP-1 receptor agonists cause colon cancer in humans

More serious but rare risks include pancreatitis, gallbladder disease, and in diabetes patients, potential worsening of diabetic retinopathy (particularly with semaglutide)

Retatrutide could become the new benchmark in obesity care

Gong Y, Chang L, Viola KL, Lacor PN, Lambert MP, Finch CE, et al